peptidio ghk cu GHK-Cu Injectable GHK-Cu 100MG - NuRev Peptides

Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing

A 250mcg dose thus requires 0.1ml (10 units on a standard insulin syringe)

Third-party testing verification and Certificate of Analysis review can confirm whether product quality might be the limiting factor

The every-5-days schedule is intentional and reflects how AMPK pathway activation works